Actiq News
Endo and Alexza Team Up - Motley Fool
Johnson & Johnson's (NYSE: JNJ) fentanyl patch Duragesic and Cephalon's (Nasdaq: CEPH) fentanyl lollipop Actiq are two of the best-known fentanyl ...
Haysville Doctor Indicted For Running "Pill Mill" - WIBW
For almost three years Schneider's clinic prescribed increasing doses of Actiq, Avinza and Valium to Robin G. On May 11, 2007, she received prescriptions ...
Endo Phase III Turns Focus To Competitive Pain Market - BioWorld Online
Actiq made up about 34 percent of Cephalon's total sales last year, and in the fall, Barr Laboratories Inc. launched a generic version that has eroded sales ...
WASTED YOUTH: A new killer in town - Brockton Enterprise
Fentanyl is typically used to treat people with severe pain, and is prescribed under the name Actiq, Duragesic and Sublimaze, according to the National ...
Lidoderm Unseats OxyContin to Top The Hartford's New List of Top ... - PharmaLive.com (press release)
The average per-dose price of Actiq (#7), already the most expensive drug used for workers' compensation patients, rose 70 percent, and the anti-depressant ...
UPDATE 2-Cephalon posts loss, agrees to settle probes - Reuters
... Pennsylvania-based company reported a third-quarter net loss due to the additional legal reserves and plunging sales of its cancer pain drug, Actiq, ...
Flushing meds: A good idea? - Chicago Tribune
According to the current federal guidelines, only certain drugs should be flushed, including Actiq (fentanyl citrate), oxycontin tablets (oxycodone) and ...
Cephalon Settles Probe, Ups Forecast - CNNMoney.com
... for "off-label" sales and marketing practices of its drugs _ epilepsy drug Gabitril, narcolepsy drug Provigil and cancer pain reliever Actiq. ...
Cephalon pays $425 million to settle claims of off-label marketing - Medical Marketing and Media
Actiq is approved by the FDA for use in cancer patients but is often prescribed by physicians off-label for other types of pain, such as migraine headaches. ...
Cephalon pays $425 million to settle claims of off-label marketing - Medical Marketing and Media
Actiq is approved by the FDA for use in cancer patients but is often prescribed by physicians off-label for other types of pain, such as migraine headaches. ...
Actiq RSS Feed